Cerus Corp CERS

Healthcare Medical Instruments & Supplies

Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

NDAQ:CERS - Post by User

Cerus Corp

Bullboard Posts

Next >>

Post by AviseAnalyticson Jan 06, 2022 8:04am

123 Views

Post# 34288300

4 STOCKS TO BUY FOR HIGHER RETURNS!

Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components for semiconductors, cutting-edge data analytics or programmatic advertising.

We take a look at some tech companies that are impervious to the scare and offer a very attractive upside in the long run. These companies not only have an excellent potential for growth and returns but have major upcoming catalysts such as contract awards, new products and services, growing client base or even global expansion plans lined up for the future.

$CERS $IRBT $PUBM $PRO

Learn More

https://www.aviseanalytics.com/4-stocks-to-buy-for-higher-returns/

Bullboard Posts

Next >>

Bombardier completes partial redemption of US$200 million